UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.221-234

2017

Link zum Volltext

Verfügbarkeit prüfen

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

The New England journal of medicine, 2012-03, Vol.366 (11), p.1000-1009

2012

Link zum Volltext

Verfügbarkeit prüfen

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis

American journal of neuroradiology : AJNR, 2020-06, Vol.41 (6), p.1001-1008

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9700), p.1503-1511

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

Neurology, 2010-06, Vol.74 (23), p.1868

2010

Link zum Volltext

Verfügbarkeit prüfen

The Central Vein Sign in Radiologically Isolated Syndrome

American journal of neuroradiology : AJNR, 2019-05, Vol.40 (5), p.776-783

2019

Link zum Volltext

Verfügbarkeit prüfen

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1079

2008

Link zum Volltext

Verfügbarkeit prüfen

Ratio of T1-Weighted to T2-Weighted Signal Intensity as a Measure of Tissue Integrity: Comparison with Magnetization Transfer Ratio in Patients with Multiple Sclerosis

American journal of neuroradiology : AJNR, 2020-03, Vol.41 (3), p.461-463

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of a New Semiautomated Segmentation Pipeline Based on the Spinal Cord Toolbox DeepSeg Algorithm to Estimate the Cervical Canal Area

American journal of neuroradiology : AJNR, 2023-07, Vol.44 (7), p.867-872

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Neurology, 2006-10, Vol.67 (7), p.1242

2006

Link zum Volltext

Verfügbarkeit prüfen

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

Neurology, 2009-01, Vol.72 (1), p.73

2009

Link zum Volltext

Verfügbarkeit prüfen

Baseline MRI predicts future attacks and disability in clinically isolated syndromes

Neurology, 2006-09, Vol.67 (6), p.968

2006

Link zum Volltext

Verfügbarkeit prüfen

MRI criteria for MS in patients with clinically isolated syndromes

Neurology, 2010-02, Vol.74 (5), p.427

2010

Link zum Volltext

Verfügbarkeit prüfen

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis

American journal of neuroradiology : AJNR, 2018-02, Vol.39 (2), p.399-404

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis

Multiple sclerosis and related disorders, 2020-11, Vol.46, p.102572-102572, Article 102572

2020

Link zum Volltext

Verfügbarkeit prüfen

SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions

American journal of neuroradiology : AJNR, 2022-04, Vol.43 (4), p.534-539

2022

Link zum Volltext

Verfügbarkeit prüfen

Brainstem lesions in clinically isolated syndromes

Neurology, 2010-11, Vol.75 (21), p.1933

2010

Link zum Volltext

Verfügbarkeit prüfen

Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields

American journal of neuroradiology : AJNR, 2016-10, Vol.37 (10), p.1816-1823

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of tumour necrosis factor (TNF)‐α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor‐associated periodic syndrome and multiple sclerosis

Clinical and experimental immunology, 2011-12, Vol.166 (3), p.338-345

2011

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months

Neurology, 2009-09, Vol.73 (12), p.949

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis

Multiple sclerosis and related disorders, 2023-12, Vol.80, p.105308, Article 105308

2023

Link zum Volltext

Verfügbarkeit prüfen

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis

American journal of neuroradiology : AJNR, 2015-12, Vol.36 (12), p.2270-2276

2015

Link zum Volltext

Verfügbarkeit prüfen

Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images

American journal of neuroradiology : AJNR, 2017-02, Vol.38 (2), p.250-256

2017

Link zum Volltext

Verfügbarkeit prüfen

Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis

American journal of neuroradiology : AJNR, 2017-08, Vol.38 (8), p.1486-1493

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI

European radiology, 2017-04, Vol.27 (4), p.1361-1368

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 362

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(336)
Mit Volltextzugriff
(301)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

The Central Vein Sign in Radiologically Isolated Syndrome

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Ratio of T1-Weighted to T2-Weighted Signal Intensity as a Measure of Tissue Integrity: Comparison with Magnetization Transfer Ratio in Patients with Multiple Sclerosis

Validation of a New Semiautomated Segmentation Pipeline Based on the Spinal Cord Toolbox DeepSeg Algorithm to Estimate the Cervical Canal Area

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

Baseline MRI predicts future attacks and disability in clinically isolated syndromes

MRI criteria for MS in patients with clinically isolated syndromes

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis

Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis

SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions

Brainstem lesions in clinically isolated syndromes

Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields

Role of tumour necrosis factor (TNF)‐α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor‐associated periodic syndrome and multiple sclerosis

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis

Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images

Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI

Aktive Filter

Suchergebnisse filtern